The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.

New study shows dementia patients who are on antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), ...

The American Heart Association issued a scientific statement highlighting the significance of mental health in maternal CV ...

A recently retired U.S. senator is calling on the Arizona legislature to pass a bill to fund clinical trials into ibogaine, ...

Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non-invasive Mental Screening).NIMS is a fast, highly accurate and cost-effect ...

BrainsWay BWAY shares plunged 15.7% in the past four trading sessions, falling below the 50-day moving average, implying ...

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.

The Food and Drug Administration on Monday granted its first approval for a pacemaker-like device for the brain to ease ...